Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Tdf-Efavirenz'
Tdf-Efavirenz published presentations and documents on DocSlides.
Switch from Efavirenz + ZDV-3TC to Efavirenz + TDF-FTC
by ramon803
SWEET Trial . Switch to Efavirenz + TDF-FTC . SWEE...
Simplification to Efavirenz-Tenofovir DF-Emtricitabine
by valerie
ADONE Trial. Simplification to Efavirenz-Tenofovir...
Switch to Etravirine from Efavirenz due to CNS Toxicity
by elena
. SSAT-029 STUDY . Switch to Etravirine from Efavi...
SHIV Infection and Drug Transporters Influence Brain Tissue Concentrations of Efavirenz
by tatiana-dople
Nithya Srinivas. 1. , John Fallon. 1. , Craig Syk...
DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
by iris
ADVANCE. . Design. Primary endpoint. Proportion ...
Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials
by luanne-stotts
Progressive rises in weight and clinical obesity ...
Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial
by keanu817
RADAR Trial. Raltegravir. + Darunavir/r versus TD...
Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV
by kylo
Andrew Hill, Francois Venter, Eric . Delaporte. , ...
Atazanavir + [Cobicistat or Ritonavir] + TDF-FTC (Phase 2)
by zane419
Study 105. Atazanavir + [Cobicistat or Ritonavir] ...
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
by shmuel184
iPrEx. Trial . Substudy. TDF-FTC versus Placebo a...
Switch to DOR-TDF-3TC vs. Continued Baseline Regimen
by dorothy
DRIVE SHIFT. Switch to Doravirine-TDF-3TC versus C...
Switching to TDF-FTC from ABC-3TC for Hyperlipidemia
by trinity
ROCKET II. Switching to TDF-FTC from ABC-3TC . for...
DTG + 3TC versus DTG + TDF-FTC as Initial ART
by della
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
Switching to TAF from TDF, each with RPV and FTC
by julia
Study GS-366-1216. Switch from TDF to TAF, each wi...
Switch from TDF to TAF
by easyho
GS-US-292-0109 Study. GS-US-311-1089 Study. . De...
Switch de TDF a TAF Estudio GS-US-292-0109
by calandra-battersby
Estudio GS-US-311-1089 . Estudio GS-US-366-1216 ....
EFFECTS ON RENAL FUNCTION OF A SWITCH FROM TENOFOVIR (TDF)
by tawny-fly
M Harris, . S Guillemi. , K Chan, B Yip. ,. . M ...
Tryptophane Metabolites Predict Neurocognitive Impairment and Side Effects during Efavirenz
by piper
A nested analysis of the Swear randomized multicen...
COMING SOON:
by luanne-stotts
GENERIC ARVs. Tim Horn. Treatment Action Group. t...
Raltegravir plus Ritonavir-Boosted Darunavir NEAT001/ANRS 143 Trial
by matthew167
NEAT001/ANRS 143 Trial. Darunavir/r + Raltegravir ...
Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112
by micah
Tenofovir. . Disoproxil. . Fumarate. to . Tenof...
Cases from the Clinic(ians): Case-based Panel Discussion
by tripp
Associate Dean for Global Health. University of Al...
Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial
by ricardo
ROCKET-1 Trial. Switch from EFV + ABC-3TC to EFV-T...
NRTI-sparing SPARTAN PROGRESS
by shepard237
RADAR. NEAT001/ANRS 14. 3 . A4001078. VEMAN. MODER...
Switching from TDF/FTC to TAF/
by fanny
FTC. Study 311-1089. Switching from TDF/FTC to TAF...
EFV versus ATV + RTV, both with ABC-3TC or TDF-FTC
by felicity
ACTG 5202. EFV versus ATV/r, both with ABC-3TC or ...
Optimization of Antiretroviral Therapy
by belinda
With Emergence of Comorbidities. Roger J. . Bedimo...
Retirement Plan Consulting
by oconnor
Overview of Services. Table of Contents. About RPA...
HIV 2020: Time for change
by garcia
Dr. Kay Mahomed. Netcare. Garden City Clinic. Ma...
Cabotegravir, Long-acting Injectable
by jacey
Last Updated: October 6, 2023. Prepared by:. David...
Jeanne Marrazzo, MD, MPH
by rose
Professor of Medicine. University of Washington. S...
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
by jasmine
–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...
Total Soluble and Insoluble Dietary Fibre Contents of Wild Growing E
by alyssa
302 Vol. 32, 2014, No. 3: 302–307Czech J. Fo...
Eric S. Daar , MD Michael S.
by ButterflyHeart
Saag. , MD. Antiretroviral Therapy:. A Case-Based ...
Renal and Bone Safety of
by ashley
Tenofovir. . Alafenamide. . vs. . Tenofovir. ....
Brad Hare Nothing to Disclose
by beatrice
Kaiser Permanente San Francisco Medical Center. Sa...
Target Date Funds and P
by unita
lan . S. ponsor Responsibilities. Marcia S. Wagner...
Selecting an Initial Antiretroviral Therapy (ART) Regimen
by cappi
www.hivguidelines.org. Purpose of . This Guideline...
937401234123534671341849346744x 19 333133Webinar Requirements A c
by erica
HBcAbThis prescribe ARTART Dispensed0-5-14 Days0-1...
ContentslistsavailableatJournalofTraceElementsinMedicineandBiologyjour
by barbara
ectofaltitudeonurinaryplasmaandnailuoridelevelsinc...
Load More...
![Atazanavir + [Cobicistat or Ritonavir] + TDF-FTC (Phase 2)](https://thumbs.docslides.com/1058605/atazanavir-cobicistat-or-ritonavir-tdf-ftc-phase-2.jpg)
